Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on July 9, 2025

Gene Matrix Launches GeneMatrixAI™: A Revolutionary Leap in Genetic Reporting
"GeneMatrixAI delivers medical-grade genomic testing with 72-hour turnaround, transforming global healthcare with precision, speed, and scalability." CHICAGO, IL, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- Gene Matrix Inc., a leading biotech and …

Vannin Healthcare Partners with Philips as Global Integrator for Turnkey Hospital Projects
The partnership will make Vannin Healthcare a global integrator of Philips’ products for its upcoming turnkey projects. LONDON, UNITED KINGDOM, July 9, 2025 /EINPresswire.com/ -- Under the agreement, Vannin Healthcare will incorporate Philips' world- …

Blue Goat Cyber Leads Medical Device Cybersecurity Compliance as FDA Finalizes New Guidance
Blue Goat Cyber leads medical device cybersecurity compliance, helping manufacturers meet the FDA’s finalized cybersecurity guidance issued June 27, 2025. SCOTTSDALE, AZ, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- On June 27, 2025, the U.S. Food …

Q2 2025 Digital Health Funding Report: Investors Back AI With Purpose as Deal Size Rebounds
AI-powered ventures lead the way as digital health funding hits $12.1B in Q2 2025, with Europe outpacing global trends and deal size rebounding. BOSTON, MA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- AI Drives Bigger Bets as Europe Surges Ahead: …

Plantation Villa Celebrates the Success of Its 200-Hour Yoga Teacher Training
Plantation Villa, Sri Lanka’s renowned wellness retreat centre, proudly reflects on the success of its 200-hour Yoga Teacher Training (YTT) held in June. HEREFORD, KINGS CAPLE, UNITED KINGDOM, July 9, 2025 /EINPresswire.com/ -- Plantation Villa, Sri …

AVERARDO ORTA (COLIBRI' GROUP), SAYS AI IS TRANSFORMING WORLD OF HEALTHCARE ON THE PLANET
"The introduction of AI in imaging has already demonstrated extraordinary results," says Averardo Orta. BOLOGNA, BOLOGNA, ITALY, July 9, 2025 /EINPresswire.com/ -- Artificial intelligence is rapidly transforming the global healthcare landscape, …

Gozellix Receives Permanent HCPCS Code
MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging agent, Gozellix® (kit for the preparation of gallium-68 ( …

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …

Helvetic Clinics: 20 % vækst bekræfter lederskab i tandturisme
Helvetic Clinics Budapest bekræfter europæisk markedslederskab inden for tandturisme med 20 % vækst i første halvdel af 2025 BUDAPEST, BUDAPEST, HUNGARY, July 9, 2025 /EINPresswire.com/ -- Helvetic Clinics, der af adskillige eksperter er anerkendt som …

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, …

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
Jason Campagna, MD, PhD, joins Inventiva as President of R…

Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R…

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 ( …

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results …

Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license …

VIIGROUP and 360Medlink Complete Merger to Deliver AI Powered Digital Medicine Solutions
Transforming Life Sciences with AI Driven, Clinically Validated Digital Medicine Solutions for Patients, Payors and Providers BETHLEHEM, PA, UNITED STATES, July 9, 2025 /EINPresswire.com/ -- VIIGROUP Inc., a leader in generative AI healthcare innovation …

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation
OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal Academy of Engineering. The award, …

Advanced Materials Market in Focus: BCC Research Publishes 2024 Sector Review
Boston, July 09, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its " 2024 Advanced Materials Research Review," offering a deep dive into one of today’s most dynamic and fast-growing markets. This comprehensive report explores the latest …